USD 0.13
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.8 Million USD | -47.06% |
2022 | 9.07 Million USD | 65.8% |
2021 | 5.47 Million USD | 14.4% |
2020 | 4.78 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 FY | 4.8 Million USD | -47.06% |
2023 Q1 | 2.38 Million USD | -89.81% |
2023 Q2 | 2.23 Million USD | -6.27% |
2022 Q2 | 1.23 Million USD | 155.98% |
2022 Q1 | 481.63 Thousand USD | 113.46% |
2022 FY | 9.07 Million USD | 65.8% |
2022 Q3 | 298.33 Thousand USD | -75.8% |
2022 Q4 | 23.36 Million USD | 7731.22% |
2021 Q2 | 528.00 USD | -93.27% |
2021 FY | 5.47 Million USD | 14.4% |
2021 Q1 | 7849.00 USD | 0.0% |
2021 Q4 | 225.63 Thousand USD | 394.96% |
2021 Q3 | 45.58 Thousand USD | 8533.9% |
2020 FY | 4.78 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Accolade, Inc. | 306.51 Million USD | 98.433% |
Aclarion, Inc. | 4.87 Million USD | 1.488% |
Aclarion, Inc. | 4.87 Million USD | 1.488% |
Augmedix, Inc. | 40.3 Million USD | 88.083% |
HeartBeam, Inc. | 15.31 Million USD | 68.636% |
HeartBeam, Inc. | 15.31 Million USD | 68.636% |
Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | 11.501% |
BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 99.627% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 99.627% |
CareCloud, Inc. | 93.35 Million USD | 94.855% |
CareCloud, Inc. | 93.35 Million USD | 94.855% |
Certara, Inc. | 254.08 Million USD | 98.11% |
CareMax, Inc. | 670.05 Million USD | 99.283% |
Definitive Healthcare Corp. | 546.47 Million USD | 99.121% |
GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.912% |
Health Catalyst, Inc. | 258.73 Million USD | 98.144% |
Healthcare Triangle, Inc. | 18.12 Million USD | 73.5% |
MSP Recovery, Inc. | 565.43 Million USD | 99.151% |
Mangoceuticals, Inc. | 9.65 Million USD | 50.229% |
National Research Corporation | 52.52 Million USD | 90.855% |
Nutex Health, Inc. | 66.54 Million USD | 92.782% |
OptimizeRx Corporation | 69.3 Million USD | 93.069% |
R1 RCM Inc. | 336.6 Million USD | 98.573% |
Renalytix Plc | 29.04 Million USD | 83.461% |
Sharecare, Inc. | 225.97 Million USD | 97.874% |
Sharecare, Inc. | 225.97 Million USD | 97.874% |
SHL Telemedicine Ltd. | 34.26 Million USD | 85.983% |
Spok Holdings, Inc. | 90.97 Million USD | 94.721% |
Streamline Health Solutions, Inc. | 31.19 Million USD | 84.6% |
TruBridge, Inc. | 206.17 Million USD | 97.67% |
10x Genomics, Inc. | 674.94 Million USD | 99.288% |
Zhongchao Inc. | 13.92 Million USD | 65.501% |